Big Announcement Alert: Discoveries meet momentum. Right here.

Fitzsimon_menu

Eye on innovators.

Each month, we feature an innovator who is making advances in health and care through the work they do here on the Fitzsimons Innovation Community campus.

Previous Innovation Spotlights:

Invenux
June 24, 2022

Invenux

Invenux, LLC, a privately held clinical stage biopharmaceutical company, is propelling its research and clinical trials forward to treat sickle cell disease in the U.S. and worldwide. By developing a botanical medicine approach, Invenux aims to break down barriers to save and change the lives of sickle cell disease patients.

READ MORE

Validus
May 27, 2022

Validus

Validus Cellular Therapeutics, Inc. is pioneering the use of cellular therapy for the treatment of drug-resistant, chronic bacterial infections. Cellular therapy approaches have been successful for oncology patients, and researchers at Colorado State University and the CU Anschutz Medical Campus discovered stem cells can also be activated to fight infections.

READ MORE

Atara Biotherapeutics
April 26, 2022

Atara Biotherapeutics

Atara Biotherapeutics is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative off-the-shelf therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases.

READ MORE

Greffex
March 25, 2022

Greffex

Greffex™ is a privately held, multi-national company that developed a novel genetic platform for the development and production of vaccines. The GREVAX™ Universal Platform delivers vaccines in a faster, more affordable, and more efficient manner in as little as four weeks.

READ MORE